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Abstract
Neonatal meningitis continues to be a problematic issue of neonatology and pediatric 
infectious diseases with its incidence of 0.8–6.1 in 1000 live births, high case fatality rate, 
and neurological sequelae. Major risk factors for contracting meningitis in the newborn 
period include maternal peripartum infection, premature rupture of membranes, prema-
ture birth, fetal hypoxia, septic or traumatic birth, low birth weight, and galactosemia. 
The leading causative agent is group B streptococci (in almost half of the cases), and a 
quarter of cases are due to Escherichia coli. Vertical transmission from the mother is often 
the route of infection. Neonatal meningitis may not be distinguishable clinically from 
neonatal sepsis without meningitis. Meticulous care should be taken to perform lum-
bar puncture whenever the patient’s status permits since it is an indispensable tool for 
diagnosis. Initial empirical therapy may consist of ampicillin and cefotaxime, ampicillin 
and gentamicin, or ampicillin + gentamicin + cefotaxime during the first week of life. 
Ampicillin + gentamicin + cefotaxime for nonhospitalized infants and the same combina-
tion with the replacement of ampicillin with vancomycin for infants still in hospital are 
suitable options after the first week.
Keywords: infants, neonate, newborns, lumbar puncture, spinal tap, meningitis
Core tips: The incidence of meningitis in newborn period is so high that is incomparable to any 
other period in human life. The case fatality rate varies between 13 and 59% with respect to coun-
try of origin. Neurological sequelae, primarily hearing loss, continue to be an important issue 
with rates of 20–58% in neonates who manage to survive this relentless disease. Enteroviruses 
and Enterobacter sakazakii, which has been detected to contaminate infant formula, are emerging 
pathogens of neonatal meningitis. cerebrospinal fluid (CSF) glucose to serum glucose ratio is 
not a reliable indicator of meningitis in the first 28 days of life, because newborns often receive 
intravenous glucose infusions and serum glucose concentrations can rise abruptly with stress. 
Lumbar puncture should always be performed as soon as the infant becomes clinically stable 
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and suitable for the procedure. If Listeria monocytogenes grows in CSF or is suspected as the caus-
ative organism from the Gram smear, it is advisable to add  ampicillin to vancomycin + genta-
micin combination, because CSF concentrations of vancomycin are not bactericidal for Listeria.
1. Introduction
Neonatal meningitis continues to retain its importance all over the world as an infectious disease 
because of its morbidity. Medical facilities that enable physicians to keep more and more prema-
ture infants alive in economically developed countries and, on the contrary side, limitations in 
access to healthcare systems in economically developing countries keep neonatal meningitis on 
the medical agenda in an era of highly developed antimicrobial management and immunization.
2. Epidemiology
The incidence of meningitis in newborn period is so high that is incomparable to any other 
period in human life. Accurate determinations of incidence may not be possible due to lack of 
reporting by healthcare personnel and difficulties encountered by patients in access to health-
care institutions in economically underdeveloped countries. Nevertheless, it is estimated that 
40,000–900,000 new cases of neonatal meningitis occur annually in these countries [1]. The 
incidence of neonatal meningitis, which is thought to be roughly one in 1000 live births, was 
reported to be 0.8–6.1 in 1000 live births in an article in which the results of 32 studies, carried 
out after 1990, have been reviewed [2].
A great progress has been made in this field of infectious diseases, at least in economically 
developed countries, with the decline of mortality rate from 50% of the past 40 years to that of 
10–15% of today; however, almost no change has occurred in neonatal meningitis in terms of 
mortality in economically developing countries and morbidity worldwide [3]. The case fatal-
ity rate varies between 13 and 59% with respect to country of origin. Neurological sequelae, 
primarily hearing loss, continue to be an important problem with rates of 20–58% in the neo-
nates who manage to survive this relentless disease [1, 4].
Turkey, once an economically developing country, where meningitis constitutes less than 1% of 
the reported causes of infant mortality, sets a good example of how natural health indices are 
affected favorably by slight increases in national income. According to the World Bank data, 
as of 2015, neonatal mortality rate in Turkey is seven per 1000 live births [an 80% decline from 
the rate (33) in 1990] [5, 6]. Yapıcıoğlu and colleagues reported the meningitis incidence as 1.4% 
among healthcare-associated infections in their university hospital’s neonatal unit in Turkey [7].
3. Risk factors
Major risk factors of neonatal meningitis are low birth weight (<2500 g), premature birth 
(before 37th week of gestation), premature rupture of membranes (before the onset of labor 
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or regular contractions), septical or traumatic birth, fetal hypoxia, maternal peripartum infec-
tion, galactosemia, and urinary tract infection [3].
4. Etiology
In economically developed countries, owing to implementation of intrapartum antibiotic pro-
phylaxis beginning in the second half of 1990s, the incidence of early-onset group B streptococ-
cus infections declined, whereas that of late-onset group B streptococcus infections remained 
the same [8]. Group B streptococci (GBS) and Escherichia coli are responsible for about half 
and a quarter of neonatal bacterial meningitis cases, respectively. These agents are succeeded 
in order of frequency by Listeria monocytogenes or Gram-negative bacteria other than E. coli 
in some texts, Streptococcus pneumoniae, group a streptococci, and nontypable Haemophilus 
influenzae. Gram-positive organisms other than GBS are encountered as pathogens more often 
in very-low-birth-weight (<1500 g) infants. Although rarely, Neisseria meningitidis may cause 
meningitis in newborns [3, 9].
Despite the data from economically developed countries, GBS predominance in neonatal 
meningitis has been observed to be replaced by Gram-negative bacteria in economically 
underdeveloped countries. Klebsiella pneumoniae is the most common Gram-negative bacillus 
and is followed in frequency by E. coli.
The most likely causative pathogens in the first three days of life are GBS, E. coli, other enteric 
bacilli, and L. monocytogenes. In addition to these, other Gram-negative organisms, such as Serratia 
marcescens, Pseudomonas aeruginosa, and Citrobacter koseri, should also be listed as likely patho-
gens in neonates of four days of age and older. In neonates who have left their first seven days 
in life behind, Acinetobacter, Stenotrophomonas, multidrug-resistant Klebsiella, and Gram-positive 
organisms that have not been mentioned above should be considered as causative agents [10].
Neonatal infections caused by herpes simplex virus (HSV) occur one in 3200–10,000 live births. 
These infections, which may manifest as neonatal meningitis, constitute 0.2% of neonatal hos-
pitalizations and 0.6% of neonatal deaths in hospital in the United States of America [11].
Fungal meningitis occurs on the grounds of risk factors, such as prematurity, central venous 
catheter, congenital immunodeficiency, and long-term antibiotic therapy. The most common 
fungal cause of neonatal meningitis is Candida albicans [12].
Enteroviruses and Enterobacter sakazakii, which has been detected to contaminate infant for-
mula, are emerging pathogens of neonatal meningitis [13, 14].
5. Pathophysiology
Neonates are apt to develop sepsis and meningitis more than all other individuals of all ages 
due to relative deficiencies in humoral and cellular immune responses. Preterm and term 
infants are deficient in complement in terms of quantity and quality, which leads to suscepti-
bility to infections by encapsulated bacteria. In infants younger than 32 weeks of gestational 
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age, transfer of maternal circulating antibodies through placenta occurs only in minute quan-
tities. Neutrophil reserves of a neonate can easily become exhausted, since they are 20–30% of 
that of an average adult [15].
The causative agent of neonatal meningitis is usually transmitted to fetus vertically during 
labor. When the etiology is bacterial, histopathologic findings of meningitis in newborns are 
similar, irrespective of the specific agent. Another similarity is observed in the inflammatory 
responses of newborns, older children, and adults, the only exception being the paucity of 
plasma cells and lymphocytes in the subacute phase of meningeal reactions in newborns. The 
most common finding is purulent exudate in meninges and ependymal surfaces of ventricles. 
Perivascular inflammation is also observed in some patients. This may further proceed to arte-
ritis of various degrees with phlebothrombosis and thrombophlebitis in the subependymal 
region. Hydrocephalus and encephalopathy were detected in half of the infants died from 
meningitis. Unlike older infants (3–12 months of age), subdural effusion is rare in neonates. 
Interleukin-1β is present in high concentrations in the meninges and brain tissue of the infants 
who have succumbed to the infection [16].
6. Physical examination
Clinical findings of neonatal meningitis are similar to those of neonatal sepsis with or without 
meningitis. It is not possible to predict with physical examination alone whether the infant 
has sepsis, meningitis or both. The most common (60%) finding is the alteration in body 
temperature. This alteration may become manifest as either fever (>38°C) or hypothermia 
(<36°C). Fever is usually observed in term infants, whereas preterms have a stronger tendency 
to develop hypothermia [3]. Skin vesicles should suggest HSV in the etiology of meningitis, 
Finding Frequency (%)
Alteration in body temperature (either hypothermia or hyperthermia) 60
Irritability or lethargy 60
Seizures 20–50
Bulging of fontanel 25
Nuchal rigidity 15
Poor feeding 50
Dyspnea 33–50
Apnea 10–30
Jaundice 28
Diarrhea 20
Table 1. Physical examination findings found in neonatal meningitis and their frequencies [1, 3].
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but vesicles may not appear in the early stages or may not occur at all through the course of 
the disease as is the case in 20% of the newborns with systemic HSV infection. In the absence 
of vesicles, it is impossible to differentiate HSV meningitis from bacterial meningitis or men-
ingitis due to other agents [11]. Seizures are seen more often in Gram-negative bacterial men-
ingitis rather than in meningitis caused by Gram-positive bacteria. It is inadvisable to rely 
on the presence of bulging anterior fontanel or nuchal rigidity, because only a few infants 
(25 and 15%, respectively) with meningitis demonstrate these signs [3]. Neurologic signs usu-
ally appear after the second day, whereas mainly systemic signs predominate in the first 48 h. 
Physical examination findings in neonatal meningitis and their frequencies are summarized 
in Table 1.
7. Laboratory tests
First tests to be performed include complete blood count with differentials and cultures (urine 
and blood). Detection of growth in urine culture could be a reflection of metastatic dissemi-
nation of the organism to the bladder, thus cannot be relied upon as a locator of infection in 
young infants [1].
Lumbar puncture (LP) is an irreplaceable diagnostic tool in neonatal meningitis. Cerebrospinal 
fluid (CSF) obtained through LP should be examined directly and as Gram- and Giemsa-
stained smears under microscope, cultured, and, if needed, sent for polymerase chain reac-
tion. Direct microscopy should be performed as soon as possible, because the later it is 
performed, the more likely the erythrocytes and leukocytes undergo cellular lysis and escape 
detection. LP should ideally precede the initiation of antimicrobial therapy, but if, delayed 
for any reason, such as deteriorating clinical status of the patient, empirical antibiotic therapy 
should be started immediately.
Interpretation of CSF findings is more difficult in neonates than in older children, since the 
glucose, protein concentrations, and cell count of CSF are higher due to the high permeability 
of the blood-brain barrier (Table 2).
Age Erythrocytes (μL/L) Leukocytes (μL/L) Protein (mg/dL) Glucose (mg/dL)
Preterm: <7 d 30 (0–333) 9 (0–30) 100 (50–290) (mostly 
<200)
54 (27–99)
Preterm: >7 d 30 12 (2–70) 90 (50–260) (mostly 
<150)
54 (27–99)
Term: <7 d 9 (0–50) 5 (0–21) 60 (30–250) 54 (27–99)
Term: >7 d <10 3 (0–10) 50 (20–80) 54 (27–99)
d: day(s).
Table 2. Means and normal ranges of cerebrospinal parameters in neonates [12].
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Many experts accept 20–30/μL as the cutoff value for pleocytosis. Decreased CSF glucose, 
increased CSF protein, and pleocytosis may indicate either bacterial or viral (especially HSV) 
meningitis. If only one of these parameters is in the normal range, this cannot be accepted as 
an evidence against the presence of meningitis. If all three parameters are normal, then it can 
be presumed that meningitis is not present; nevertheless, keeping in mind that completely 
normal CSF findings may be observed during the very early course of neonatal meningitis, 
the most prudent approach would be to repeat LP after 24–72 h in such borderline cases. If the 
infant had meningitis, pleocytosis and other abnormalities consistent with meningitis would 
be detected in CSF obtained in this second LP [3]. Ample number of erythrocytes in CSF may 
be interpreted as a clue to HSV meningitis if the physician is sure that the LP was not trau-
matic. Pleocytosis is more marked in bacterial and Gram-negative meningitides than in viral 
and Gram-positive meningitides [1].
CSF protein concentrations higher than 100 mg/dL in term infants and 150 mg/dL in preterm 
neonates are consistent with bacterial meningitis. CSF protein may also be found to be high 
in parameningeal infections like brain abscess, congenital infections, and intracranial hemor-
rhage [3].
The glucose concentration is said to be consistent with bacterial meningitis if it is below 30 mg/dL 
in term newborns and 20 mg/dL in preterm infants. CSF glucose to serum glucose ratio is not a reli-
able indicator of meningitis in the first 28 days of life, because newborns often receive intravenous 
glucose infusions and serum glucose concentrations can rise abruptly with stress [3]. In case of a 
bloody tap, assessing the CSF leucocyte count by correcting it with respect to that of the peripheral 
blood is not recommended in that it decreases the sensitivity and provides only a slight increase 
in specificity. When LP is traumatic, the wisest thing to do is to assume the patient as if she/he had 
meningitis and start empirical therapy [17]. Since sitting position with the legs flexed provides the 
widest interspinous spaces and it is sufficiently safe, it should be favored for sick neonates when-
ever the infant’s condition permits a spinal tap [18].
Although, as noted above, signs of sepsis and meningitis intertwine in the newborn period, 
some neonatologists consider that it is unnecessary to perform LP on neonates evaluated for 
sepsis, especially those with early neonatal sepsis [19, 20]. Blood cultures are negative in one-
third of neonates with meningitis who are very low birth weight and born over 34 weeks of 
gestation [1]. Thus, in case LP is not performed, a significant portion of neonates with menin-
gitis would not get a correct diagnosis and would not be observed for the likely complications 
of meningitis; for that reason, the author is in favor of the opinion that LP should always be 
performed as soon as the infant becomes clinically stable and can tolerate the procedure if it 
has not been possible to be performed at the first suspicion of meningitis. It should be kept 
in mind that findings of CSF inflammation last for a considerably long duration (days, some-
times weeks), which allows the clinician diagnose or exclude the diagnosis of meningitis.
Ultrasonography is valuable in the follow-up, especially for the cases, in which hydrocepha-
lus has developed as a complication of meningitis. If the disadvantage of radiation exposure 
is left aside, computed tomography can accelerate the decision making of ventriculostomy 
in cases of hydrocephalus and surgical drainage in patients with cranial abscesses. Magnetic 
resonance (MR) is the imaging modality of choice in conditions, such as focal neurologic 
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abnormalities, resistant infection, and clinical deterioration. MR is the most precise tool for 
the diagnosis of complications, like sinus vein thrombosis, ventriculitis, and subdural depos-
its. Electroencephalography has no diagnostic value in neonatal meningitis [12].
8. Diagnosis
History of premature or prolonged labor, intrauterine scalp monitorization, traumatic birth, 
and maternal peripartum infection should be noted.
Physical signs may be subtle in neonatal meningitis, in which either fever or hypothermia 
may be the only clue to diagnosis. Pleocytosis under direct microscopy or the presence of 
bacteria in Gram smear suggests meningitis. Definitive diagnosis is made with the isolation 
of causative organism in CSF.
The differential diagnosis includes other causes of neonatal seizures, partially treated men-
ingitis, intracranial abscess, intracranial hemorrhage, intracranial aneurysm, cerebral vein 
thrombosis, head trauma, and congenital metabolic diseases.
9. Management
In the meningitides with the onset in the first 3–6 days of life, the empirical therapy should be 
ampicillin + cefotaxime, ampicillin + gentamicin, or, if there is a very high probability that the 
causative organism is Gram negative, as in the case of detection of Gram-negative bacilli on 
smear, it should be ampicillin + gentamicin + cefotaxime [10].
After the first 3–6 days of life, ampicillin + gentamicin + cefotaxime for infants from outside 
of a healthcare facility, and vancomycin + gentamicin + cefotaxime for previously or currently 
hospitalized newborns would be appropriate choices [1, 10]. If L. monocytogenes grows in CSF 
or is suspected as the pathogen from the Gram smear, it is advisable to add ampicillin to 
vancomycin + gentamicin combination, because CSF concentrations of vancomycin are not 
bactericidal for Listeria [10].
Dosages of recommended drugs are depicted in Table 3.
Dexamethasone therapy, which is used for older children, is not recommended for neonatal 
meningitis [1, 10].
Acyclovir (20 mg/kg/dose, every 8 h, for 14–21 days) should be administered to all neonates 
with HSV disease, regardless of manifestations and clinical findings [21].
For newborns whose CSF shows growth of a pathogen, the duration of therapy should be 
14 days for Gram-positive organisms and 21 days for Gram negatives if neither any complica-
tion nor resistance to therapy is present. If a growth is detected in blood culture but not in 
CSF, while CSF shows signs of inflammation, a therapy duration of 10 days for Gram-positive 
organisms and 14 days for Gram negatives would suffice. Empirical antimicrobial therapy 
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for well-appearing infants with negative blood and CSF cultures and negative inflamma-
tory findings in CSF may safely be discontinued 48–72 h after receiving negative CSF culture 
results from the microbiology laboratory [10].
LP should be repeated after 24–48 h after the beginning of antimicrobials for CSF is expected 
to become sterile in 24–48 h with appropriate therapy. In some centers, successful therapy for 
HSV meningitis is confirmed with a negative polymerase chain reaction in CSF, obtained with 
a repeat LP at the end of a 21-day antiviral therapy.
10. Complications and follow-up
Early complications of neonatal meningitis are increased: intracranial pressure, ventriculitis, 
cerebritis, hydrocephalus, brain abscess, cerebral infarction, and subdural effusion or empyema 
[22]. Late complications include hearing loss, abnormal behaviors, developmental retardation, 
cerebral palsy, focal motor deficits, seizures, and hydrocephalus, some of which may develop 
due to neonatal sepsis or cerebritis in infants without meningitis. Neonates recovered from 
meningitis should be referred for brainstem evoked auditory response audiometry 6–8 weeks 
after completion of therapy and then followed regularly for visual, auditory, and cognitive 
functions.
11. Prognosis
Case fatality rate is highest in meningitides due to Gram-negative organisms (17%), which are 
succeeded by those caused by fungi (12%) and Gram-positive bacteria (6%) [10, 23].
12. Conclusion
Taking Turkey as an example, a PubMed search by the author using the Medical Subject 
Headings terms groups “infant meningitis Turkey,” “newborn meningitis Turkey,” “neo-
nate meningitis Turkey,” “infant meningitis Turkish,” “newborn meningitis Turkish,” and 
Weight < 1200 g Weight = 1200–2 000 g Weight = 1200–2000 g Weight > 2000 g Weight > 2000 g
Antibiotic Age: 0–4 wk Age: 0–7 d Age > 7 d Age: 0–7 d Age > 7 d
Ampicillin 50, every 12 h 50, every 12 h 50, every 8 h 50, every 8 h 50, every 6 h
Gentamicin 2.5, every 18 h 2.5, every 12 h 2.5, every 8 h 2.5, every 12 h 2.5, every 8 h
Cefotaxime 50, every 12 h 50, every 12 h 50, every 8 h 50, every 12 h 50, every 8 h
Vancomycin 15, every 24 h 10, every 12 h 10, every 12 h 10, every 8 h 10, every 8 h
wk: week(s); d: day(s); h: hour(s).
Table 3. Dosages (mg/kg) of some antibacterial drugs used for neonatal meningitis [15].
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“ neonate meningitis Turkish” revealed only two recent, relatively large-scale studies on the 
epidemiology of neonatal meningitis in Turkey, which points to the need for more local data 
in this field [24, 25].
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